Antenatal screening for Toxoplasma gondii infection at a tertiary care hospital in Riyadh, Saudi Arabia

Annals of Saudi Medicine

Volumn 31, Issue 6, 2011, Pages 569-572

  Almogren, Adel ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTOZOON ANTIBODY;

ADULT; ARTICLE; FEMALE; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; SAUDI ARABIA; SEROPREVALENCE; TERTIARY HEALTH CARE; TOXOPLASMA GONDII; TOXOPLASMOSIS; BLOOD; IMMUNOLOGY; MASS SCREENING; NEWBORN; ORGANIZATION AND MANAGEMENT; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREVALENCE; PROCEDURES; RETROSPECTIVE STUDY; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

ADULT; ANTIBODIES, PROTOZOAN; FEMALE; HUMANS; INFANT, NEWBORN; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL CARE; PREVALENCE; RETROSPECTIVE STUDIES; SAUDI ARABIA; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 81255140976     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.87090     Document Type: Article

References (41)

1. Gilbert RE. Epidemiology of infection in pregnant women. In: Petersen E, Amboise-Thomas P, editors. Congenital toxoplasmosis: Scientific background, clinical management and control. Paris: Springer-Verlag France; 1999.
2. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994;330:1858-63. (Pubitemid 24188138)
3. Koppe JG, Loewer Sieger DH, de Roever Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986;1:254-6. (Pubitemid 16132862)
4. Lappalainen M, Koskiniemi M, Hiilesmaa V, Ammälä P, Teramo K, Koskela P, et al. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. Pediatr Infect Dis J 1995;14:354-61.
5. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999;353:1834-7. (Pubitemid 29251015)
6. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn. 4th ed. Pennsylvania: WB Saunders; 1995. p. 140-267.
7. Hall SM. Congenital toxoplasmosis. BMJ 1992;305:291-7.
8. Newton LH, Hall SM. A survey of health education material for the primary prevention of congenital toxoplasmosis. Commun Dis Rep CDR Rev 1995;5:R21-7.
9. Thiebaut R, Leproust S, Chene G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: A meta-analysis of individual patients' data. SYROCOT (Systematic Review on Congenital Toxoplasmosis) Study Group. Lancet 2007;369:115-22.
10. Emna S, Karim A, Mohammed K, Aida B. Difficulty in dating primary infections by Toxoplasma gondii in pregnant women in Tunisia. Tunis Med 2006;84:85-7. (Pubitemid 43799304)
11. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counseling. Lancet 1999;353:1829-33. (Pubitemid 29251014)
12. Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, Dunn DT. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: Retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 2001;30:1303-8. (Pubitemid 34134278)
13. Sabin AB. Dyes as microchemical indicators of a new phenomenon affecting a protozoan parasite toxoplasma. Science 1948;108:660-3.
14. Desmonts G, Remington JS. Direct agglutination test for diagnosis of Toxoplasma infection: Method for increasing sensitivity and specificity. J Clin Microbiol 1980;11:562-8. (Pubitemid 10119952)
15. Naot Y, Remington JS. An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: Use for diagnosis of acute acquired toxoplasmosis. J Infect Dis 1980;142:757-66. (Pubitemid 11138431)
16. Remington JS, McLeod R. Toxoplasmosis. In: Gorbach SL, Bartlett JG, Blacklow NR, editors. Infectious diseases. Philadelphia: WB Saunders Company; 1992. p. 1328-43.
17. Pelloux H, Fricker-Hidalgo H, Goullier-Fleuret A, Ambroise-Thomas P. Detection of anti-toxoplasma immunoglobulin M in pregnant women. J Clin Microbiol 1997;35:2187. (Pubitemid 27318738)
18. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: The Platelia Toxo IgM test. J Clin Microbiol 1997;35:174-8. (Pubitemid 26422649)
19. Turunen H, Vuorio KA, Leinikki PO. Determination of IgG, IgM and IgA antibody responses in human toxoplasmosis by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis 1983;15:307-11. (Pubitemid 13019680)
20. Ashburn D, Joss AW, Pennington TH, Ho-Yen DO. Do IgA, IgE and IgG avidity tests have any value in the diagnosis of toxoplasma infection in pregnancy? J Clin Pathol 1998;51:312-5. (Pubitemid 28281004)
21. Nissapatorn V, Noor Azmi MA, Cho SM, Fong MY, Init I, Rohela M, et al. Toxoplasmosis: Prevalence and risk factors. J Obstet Gynaecol 2003;23:618-24. (Pubitemid 37475898)
22. Koskiniemi M, Lappalainen M, Koskela P, Hedman K, Ammälä P, Hiilesmaa V, et al. The program for antenatal screening of toxoplasmosis in Finland: A prospective cohort study. Scand J Infect Dis Suppl 1992;84:70-4. (Pubitemid 23048977)
23. Lappalainen M, Koskela P, Hedman K, Teramo K, Ammälä P, Hiilesmaa V, et al. Incidence of primary toxoplasma infections during pregnancy in southern Finland: A prospective cohort study. Scand J Infect Dis 1992;24:97-104.
24. Morris A, Croxson M. Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland. N Z Med J 2004;117:U770.
25. Ertug S, Okyay P, Turkmen M, Yuksel H. Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health 2005;5:66.
26. Nowakowska D, Slaska M, Kostrzewska E, Wilczy-ski J. Anti -T. gondii antibody concentration in sera of pregnant women in the sample of Lód-population. Wiad Parazytol 2001;47:83-9.
27. Han K, Shin DW, Lee TY, Lee YH. Seroprevalence of Toxoplasma gondii infection and risk factors associated with seropositivity of pregnant women in Korea. J Parasitol 2008;94:963-5
28. Iqbal J, Khalid N. Detection of acute Toxoplasma gondii infection in early pregnancy by IgG avidity and PCR analysis J Med Microbiol. 2007;56:1495-9. (Pubitemid 350175076)
29. Decavalas G, Papapetropoulou M, Giannoulaki E, Tzigounis V, Kondakis XG. Prevalence of Toxoplasma gondii antibodies in gravidas and recently aborted women and study of risk factors. Eur J Epidemiol 1990;6:223-6. (Pubitemid 20352897)
30. Dupouy Camet J, Gavinet MF, Paugam A, Tourte Schaeffer C. Transmission, incidence and prevalence of toxoplasmosis. Med Mal Infect 1993;23:139-47. (Pubitemid 23119741)
31. Gilbert RE, Tookey PA, Cubitt WD, Ades AE, Masters J, Peckham CS. Prevalence of toxoplasma IgG among pregnant women in west London according to country of birth and ethnic group. BMJ 1993;306:185. (Pubitemid 23023787)
32. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. BMJ 2000;321:142-7. (Pubitemid 30447005)
33. Dubey JP. Strategies to reduce transmission of Toxoplasma gondii to animals and humans. Vet Parasitol 1996;64:65-70. (Pubitemid 26316316)
34. Dubey JP. Toxoplasmosis in sheep, goats, pigs and cattle. In: Dubey J, Beattie C, editors. Toxoplasmosis in animals and man. Boca Raton, Florida: CRC Press; 1988. p. 61-114.
35. Desmonts G, Couvreur J, Alison F, Baudelot J, Gerbeaux J, Lelong M. Epidemiological study on toxoplasmosis: The influence of cooking slaughter-animal meat on the incidence of human infection. Rev Fr Etud Clin Biol 1965;10:952-8.
36. Smith JL. Foodborne toxoplasmosis. J Food Safety 1991;12:17-57.
37. Kapperud G, Jenum PA, Stray Pedersen B, Melby KK, Eskild A, Eng J. Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol 1996;144:405-12. (Pubitemid 26262204)
38. Baril L, Ancelle T, Thulliez P, Goulet V, Tirard V, Carme B. Facteurs de risque d'aquisition de la toxoplasmose chez les femmes enceintes en 1995 (France). Bulletin Epidemiologique Hebdomadaire 1996;16:73-5.
39. Kravetz JD, Federman DG. Prevention of toxoplasmosis in pregnancy: Knowledge of risk factors. Infect Dis Obstet Gynecol 2005;13:161-5. (Pubitemid 41445028)
40. Pawlowski ZS, Gromadecka-Sutkiewicz M, Skommer J, Paul M, Rokossowski H, Suchocka E, et al. Impact of health education on knowledge and prevention behavior for congenital toxoplasmosis: The experience of Poznan, Poland, Health Educ Res 2001;16:493-502. (Pubitemid 32769164)
41. Foulon W, Naessens A, Ho-Yen D. Prevention of congenital toxoplasmosis. J Perinat Med 2000;28:337-45. (Pubitemid 32952974)